CS
Chandran Sathishkumar
About Chandran Sathishkumar
Data last updated:
Chandran Sathishkumar is a Director at Bageo Pharmaceuticals Private Limited (since 2021). The company operates in Business Services. Bageo Pharmaceuticals Private Limited reported revenue of ₹1.24 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Nov 2021 | 2019 | ₹1.24 Cr (FY 2022) | Active |
Board colleagues of Chandran Sathishkumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Balachandar Chinnasamy | 08341822 | Bageo Pharmaceuticals Private Limited | Director |
| Mohammed Abdul Salam Mohamed Abdul Rahim | 08341834 | Bageo Pharmaceuticals Private Limited | Director |
| Suriyan Chandrasekar | 08341833 | Bageo Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandran Sathishkumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandran Sathishkumar
Chandran Sathishkumar currently holds 1 directorship: Bageo Pharmaceuticals Private Limited (Director, since 30 Nov 2021, revenue ₹1.24 Cr (FY 2022)).
Chandran Sathishkumar was first appointed on 30 Nov 2021 as Director at Bageo Pharmaceuticals Private Limited.
The current boards of Chandran Sathishkumar's companies include Balachandar Chinnasamy (Bageo Pharmaceuticals Private Limited), Mohammed Abdul Salam Mohamed Abdul Rahim (Bageo Pharmaceuticals Private Limited), Suriyan Chandrasekar (Bageo Pharmaceuticals Private Limited).